Amneal Forms New Subsidiary for Complex Generic Drugs

Amneal Pharmaceuticals, a supplier of generic drugs, has formed Amneal Biosciences, a wholly owned subsidiary of Amneal Pharmaceuticals LLC, which will focus exclusively on the commercialization of high-barrier-to-entry generic and specialty pharmaceuticals such as injectables, oncologics, and biosimilars.

Charles Lucarelli has been named president of Amneal Biosciences. He joined Amneal in March 2015 after a 37-year career at Memorial Sloan Kettering Cancer Center, including 25 years as director of pharmacy. In this position, Mr. Lucarelli took direct responsibility for the pharmacy department and its regional sites and was accountable for inpatient/outpatient pharmaceutical services, clinical services, and hospital-wide investigational drug and research services. Charles was a co-investigator on numerous drug studies at Memorial Sloan Kettering.

Source: Amneal Pharmaceuticals

Leave a Reply

Your email address will not be published. Required fields are marked *